NovAccess Global Inc. (OTCMKTS:XSNX) Sees Large Increase in Short Interest

NovAccess Global Inc. (OTCMKTS:XSNX) was the target of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 17,300 shares, an increase of 408.8% from the September 30th total of 3,400 shares. Based on an average daily volume of 87,100 shares, the short-interest ratio is currently 0.2 days.

NovAccess Global Price Performance

Shares of OTCMKTS XSNX opened at $0.00 on Friday. The stock has a market capitalization of $178,412.00, a PE ratio of -0.03 and a beta of 1.82. NovAccess Global has a one year low of $0.00 and a one year high of $0.06. The business’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.01.

About NovAccess Global

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.